MAPT anticorps (AA 34-368)

N° du produit ABIN7434482

Cet anticorps anti-MAPT est un anticorps Lapin Polyclonal détectant MAPT dans WB, IHC, IP et ICC. Adapté pour Rat.

Aperçu rapide pour MAPT anticorps (AA 34-368) (ABIN7434482)

Highlights:

• High quality MAPT Anticorps primaire for the detection of MAPT.
• Reliable product with high standard validation data

Antigène: MAPT (Microtubule-Associated Protein tau (MAPT))

Reactivité: Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MAPT est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Détail du produit anti-MAPT anticorps

Épitope: AA 34-368

Fonction: Polyclonal Antibody to Tau Protein (MAPT)

Specificité: The antibody is a rabbit polyclonal antibody raised against MAPT. It has been selected for its ability to recognize MAPT in immunohistochemical staining and western blotting.

Réactivité croisée: Souris

Purification: Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Immunogène: Recombinant Tau Protein (MAPT) corresdonding to Ala34~Ser368 with N-terminal His Tag

Isotype: IgG

Informations sur le produit:

What can the MAPT Antibody ABIN7434482 be used for?: This polyclonal MAPT Antibody detects MAPT. The MAPT Antibody has been validated for various applications and can be used for the detection of MAPT and derivatives by Western Blotting, Immunohistochemistry, Immunoprecipitation, Immunocytochemistry.

What validation data is available for this MAPT Antibody?: The Anticorps primaire has currently 5 product images that show its performance in a variety of applications. The product is currently available in 1 mL, 20 μL, 100 μL, 200 μL quantities. MAPT Antibody for the detection of MAPT and derivatives.

What is the function of MAPT?: This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008].

Information d'application

Indications d'application: Western blotting: 0.5-2 μg/mL,Immunohistochemistry: 5-20 μg/mL,Immunocytochemistry: 5-20 μg/mL,Optimal working dilutions must be determined by end user.

Commentaires:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Date de péremption: 24 months

Détails sur MAPT

Antigène: MAPT (Microtubule-Associated Protein tau (MAPT))

Autre désignation: MAPT

Sujet: DDPAC, FTDP-17, MAPTL, MSTD, MTBT1, MTBT2, PPND, Neurofibrillary tangle protein, Microtubule Associated Protein Tau, Paired helical filament-tau, G Protein Beta1/Gamma2 Subunit-Interacting Factor 1

UniProt: P19332

Pathways: Signalisation MAPK, Dynamique des Microtubules, M Phase, Regulation of Cell Size